Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia

The critical question in the management of chronic myelomonocytic leukemia (CMML) is which patients may benefit from allogeneic hematopoietic cell transplantation (allo-HCT). Using ad hoc statistical analysis, we designed a multicenter retrospective study to determine outcomes in 261 patients age &l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gagelmann, Nico (VerfasserIn) , Bogdanov, Rashit (VerfasserIn) , Stoelzel, Friedrich (VerfasserIn) , Rautenberg, Christina (VerfasserIn) , Panagiota, Victoria (VerfasserIn) , Becker, Heiko (VerfasserIn) , Radujković, Aleksandar (VerfasserIn) , Luft, Thomas (VerfasserIn) , Christopeit, Maximilian Erich Joachim (VerfasserIn) , Finke, Jürgen (VerfasserIn) , Platzbecker, Uwe (VerfasserIn) , Ditschkowski, Markus (VerfasserIn) , Schroeder, Thomas (VerfasserIn) , Koldehoff, Michael (VerfasserIn) , Heuser, Michael (VerfasserIn) , Kobbe, Guido (VerfasserIn) , Beelen, Dietrich W. (VerfasserIn) , Germing, Ulrich (VerfasserIn) , Kroeger, Nicolaus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2021
In: Transplantation and cellular therapy
Year: 2021, Jahrgang: 27, Heft: 1, Pages: 95.e1-95.e4
ISSN:2666-6367
DOI:10.1016/j.bbmt.2020.10.007
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bbmt.2020.10.007
Volltext
Verfasserangaben:Nico Gagelmann, Rashit Bogdanov, Friedrich Stoelzel, Christina Rautenberg, Victoria Panagiota, Heiko Becker, Aleksandar Radujkovic, Thomas Luft, Maximilian Christopeit, Jurgen Finke, Uwe Platzbecker, Markus Ditschkowski, Thomas Schroeder, Michael Koldehoff, Michael Heuser, Guido Kobbe, Dietrich W. Beelen, Ulrich Germing, Nicolaus Kroeger

MARC

LEADER 00000caa a2200000 c 4500
001 178021085X
003 DE-627
005 20230427104148.0
007 cr uuu---uuuuu
008 211203s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.bbmt.2020.10.007  |2 doi 
035 |a (DE-627)178021085X 
035 |a (DE-599)KXP178021085X 
035 |a (OCoLC)1341434679 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gagelmann, Nico  |e VerfasserIn  |0 (DE-588)1203322240  |0 (DE-627)168815017X  |4 aut 
245 1 0 |a Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia  |c Nico Gagelmann, Rashit Bogdanov, Friedrich Stoelzel, Christina Rautenberg, Victoria Panagiota, Heiko Becker, Aleksandar Radujkovic, Thomas Luft, Maximilian Christopeit, Jurgen Finke, Uwe Platzbecker, Markus Ditschkowski, Thomas Schroeder, Michael Koldehoff, Michael Heuser, Guido Kobbe, Dietrich W. Beelen, Ulrich Germing, Nicolaus Kroeger 
264 1 |c January 2021 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.12.2021 
520 |a The critical question in the management of chronic myelomonocytic leukemia (CMML) is which patients may benefit from allogeneic hematopoietic cell transplantation (allo-HCT). Using ad hoc statistical analysis, we designed a multicenter retrospective study to determine outcomes in 261 patients age <= 70 years at diagnosis who underwent allo-HCT (n = 119) compared with those who did not (n = 142) according to the current CMML-specific prognostic scoring system (CPSS). Categorizing patients as lower risk (CPSS low/intermediate-1) or higher risk (intermediate-2/high) showed significantly improved outcomes after transplantation in higher-risk patients, with a 37% reduced hazard for death. However, although higher CPSS was associated with worse outcomes in the non-transplantation group, the score was of limited utility for post-transplantation risk stratification. This study may provide further support for the potentially beneficial role of allo-HCT in terms of long-term survival in higher-risk patients but also underscores the need for transplantation-specific risk assessment. Recognizing limitations of retrospective comparisons, larger and prospective comparisons are needed to further refine the indication for allo-HCT and thus counseling of patients with CMML. (C) 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. 
650 4 |a Allogeneic hematopoietic stem cell transplantation 
650 4 |a blood 
650 4 |a Chronic myelonocytic leukemia 
650 4 |a european group 
650 4 |a Hypomethylating agents 
650 4 |a Prognosis 
650 4 |a recommendations 
650 4 |a Supportive care 
700 1 |a Bogdanov, Rashit  |e VerfasserIn  |4 aut 
700 1 |a Stoelzel, Friedrich  |e VerfasserIn  |4 aut 
700 1 |a Rautenberg, Christina  |e VerfasserIn  |0 (DE-588)1184308276  |0 (DE-627)1663465401  |4 aut 
700 1 |a Panagiota, Victoria  |e VerfasserIn  |4 aut 
700 1 |a Becker, Heiko  |d 1978-  |e VerfasserIn  |0 (DE-588)1124562494  |0 (DE-627)878761993  |0 (DE-576)482834307  |4 aut 
700 1 |a Radujković, Aleksandar  |d 1980-  |e VerfasserIn  |0 (DE-588)132951320  |0 (DE-627)529183536  |0 (DE-576)299523721  |4 aut 
700 1 |a Luft, Thomas  |e VerfasserIn  |0 (DE-588)1078976309  |0 (DE-627)839996969  |0 (DE-576)452120659  |4 aut 
700 1 |a Christopeit, Maximilian Erich Joachim  |d 1975-  |e VerfasserIn  |0 (DE-588)129109495  |0 (DE-627)389661465  |0 (DE-576)297498169  |4 aut 
700 1 |a Finke, Jürgen  |e VerfasserIn  |0 (DE-588)1096178028  |0 (DE-627)856561029  |0 (DE-576)467887586  |4 aut 
700 1 |a Platzbecker, Uwe  |e VerfasserIn  |0 (DE-588)115567089  |0 (DE-627)647686228  |0 (DE-576)337938695  |4 aut 
700 1 |a Ditschkowski, Markus  |d 1971-  |e VerfasserIn  |0 (DE-588)122451554  |0 (DE-627)705913112  |0 (DE-576)293277281  |4 aut 
700 1 |a Schroeder, Thomas  |d 1980-  |e VerfasserIn  |0 (DE-588)1138227749  |0 (DE-627)895546574  |0 (DE-576)492416435  |4 aut 
700 1 |a Koldehoff, Michael  |e VerfasserIn  |0 (DE-588)1206348569  |0 (DE-627)169234241X  |4 aut 
700 1 |a Heuser, Michael  |d 1974-  |e VerfasserIn  |0 (DE-588)130051918  |0 (DE-627)488792959  |0 (DE-576)297970534  |4 aut 
700 1 |a Kobbe, Guido  |d 1967-  |e VerfasserIn  |0 (DE-588)122013174  |0 (DE-627)08168181X  |0 (DE-576)293047596  |4 aut 
700 1 |a Beelen, Dietrich W.  |e VerfasserIn  |0 (DE-588)171970446  |0 (DE-627)696866145  |0 (DE-576)132847566  |4 aut 
700 1 |a Germing, Ulrich  |d 1965-  |e VerfasserIn  |0 (DE-588)114105774  |0 (DE-627)607396474  |0 (DE-576)309781612  |4 aut 
700 1 |a Kroeger, Nicolaus  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Transplantation and cellular therapy  |d [Amsterdam] : Elsevier B. V., 2021  |g 27(2021), 1, Seite 95.e1-95.e4  |h Online-Ressource  |w (DE-627)1750919230  |w (DE-600)3056525-X  |x 2666-6367  |7 nnas  |a Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia 
773 1 8 |g volume:27  |g year:2021  |g number:1  |g pages:95.e1-95.e4  |g extent:4  |a Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia 
856 4 0 |u https://doi.org/10.1016/j.bbmt.2020.10.007  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211203 
993 |a Article 
994 |a 2021 
998 |g 1078976309  |a Luft, Thomas  |m 1078976309:Luft, Thomas  |d 910000  |d 910100  |d 50000  |e 910000PL1078976309  |e 910100PL1078976309  |e 50000PL1078976309  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 8 
998 |g 132951320  |a Radujković, Aleksandar  |m 132951320:Radujković, Aleksandar  |d 910000  |d 910100  |d 50000  |e 910000PR132951320  |e 910100PR132951320  |e 50000PR132951320  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
999 |a KXP-PPN178021085X  |e 4013533049 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"note":["Gesehen am 03.12.2021"],"relHost":[{"note":["Gesehen am 10.03.21"],"recId":"1750919230","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"TCT"}],"language":["eng"],"pubHistory":["Volume 27, issue 1 (January 2021)-"],"title":[{"title_sort":"Transplantation and cellular therapy","title":"Transplantation and cellular therapy"}],"disp":"Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemiaTransplantation and cellular therapy","origin":[{"dateIssuedKey":"2021","publisherPlace":"[Amsterdam]","publisher":"Elsevier B. V.","dateIssuedDisp":"2021-"}],"part":{"text":"27(2021), 1, Seite 95.e1-95.e4","year":"2021","pages":"95.e1-95.e4","issue":"1","volume":"27","extent":"4"},"id":{"zdb":["3056525-X"],"eki":["1750919230"],"issn":["2666-6367"]}}],"physDesc":[{"extent":"4 S."}],"recId":"178021085X","name":{"displayForm":["Nico Gagelmann, Rashit Bogdanov, Friedrich Stoelzel, Christina Rautenberg, Victoria Panagiota, Heiko Becker, Aleksandar Radujkovic, Thomas Luft, Maximilian Christopeit, Jurgen Finke, Uwe Platzbecker, Markus Ditschkowski, Thomas Schroeder, Michael Koldehoff, Michael Heuser, Guido Kobbe, Dietrich W. Beelen, Ulrich Germing, Nicolaus Kroeger"]},"title":[{"title_sort":"Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia","title":"Long-term survival benefit after allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1016/j.bbmt.2020.10.007"],"eki":["178021085X"]},"person":[{"given":"Nico","role":"aut","display":"Gagelmann, Nico","family":"Gagelmann"},{"given":"Rashit","display":"Bogdanov, Rashit","role":"aut","family":"Bogdanov"},{"family":"Stoelzel","role":"aut","display":"Stoelzel, Friedrich","given":"Friedrich"},{"family":"Rautenberg","display":"Rautenberg, Christina","role":"aut","given":"Christina"},{"given":"Victoria","display":"Panagiota, Victoria","role":"aut","family":"Panagiota"},{"given":"Heiko","role":"aut","display":"Becker, Heiko","family":"Becker"},{"given":"Aleksandar","display":"Radujković, Aleksandar","role":"aut","family":"Radujković"},{"given":"Thomas","display":"Luft, Thomas","role":"aut","family":"Luft"},{"family":"Christopeit","role":"aut","display":"Christopeit, Maximilian Erich Joachim","given":"Maximilian Erich Joachim"},{"role":"aut","display":"Finke, Jürgen","family":"Finke","given":"Jürgen"},{"given":"Uwe","display":"Platzbecker, Uwe","role":"aut","family":"Platzbecker"},{"given":"Markus","family":"Ditschkowski","display":"Ditschkowski, Markus","role":"aut"},{"given":"Thomas","display":"Schroeder, Thomas","role":"aut","family":"Schroeder"},{"family":"Koldehoff","role":"aut","display":"Koldehoff, Michael","given":"Michael"},{"role":"aut","display":"Heuser, Michael","family":"Heuser","given":"Michael"},{"given":"Guido","role":"aut","display":"Kobbe, Guido","family":"Kobbe"},{"display":"Beelen, Dietrich W.","role":"aut","family":"Beelen","given":"Dietrich W."},{"given":"Ulrich","family":"Germing","role":"aut","display":"Germing, Ulrich"},{"given":"Nicolaus","family":"Kroeger","role":"aut","display":"Kroeger, Nicolaus"}],"origin":[{"dateIssuedDisp":"January 2021","dateIssuedKey":"2021"}]} 
SRT |a GAGELMANNNLONGTERMSU2021